Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Limited has announced a new application for the quotation of securities, specifically 5,674,635 ordinary fully paid shares, under the ASX security code TLX. The issue date for these securities is April 11, 2024. This move is expected to draw attention from investors and could potentially impact the company’s stock performance on the ASX.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
